PharVision Advisers »

Vericel shares owned by PharVision Advisers

Quarter-by-quarter ownership of Vericel (VCEL) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Vericel

Tip: Access up to 7 years of quarterly data

All positions including Vericel held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vericel by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $394k 11k 36.01

More positions owned by PharVision Advisers

ExlService Holdings (EXLS)
Delek Us Holdings (DK)
Fiverr Intl Ord Shs (FVRR)
Asana Cl A (ASAN)
Broadcom (AVGO)
Itron (ITRI)
Brinker International (EAT)
Herbalife Com Shs (HLF)
NVIDIA Corporation (NVDA)
Evolv Technologies Hldngs In Com Cl A (EVLV)
Las Vegas Sands (LVS)
Vici Pptys (VICI)
Century Aluminum Company (CENX)
Agilent Technologies Inc C ommon (A)
Vail Resorts (MTN)

View all positions for PharVision Advisers

Top funds holding Vericel

BlackRock
Vanguard Group
State Street Corporation
Conestoga Capital Advisors
William Blair Investment Management
FMR
Geneva Capital Management
Congress Asset Management
Jennifer Ranahan
Bnp Paribas Investment Partners
Geode Capital Management
Loomis, Sayles and
Champlain Investment Partners
Royal Bank of Canada
Brown Capital Management

View all funds holding Vericel